New Genetics and Society

Papers
(The TQCC of New Genetics and Society is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Governance through scientism: Taiwan Biobank and public controversy16
Human heritable genome editing and its governance: views of scientists and governance professionals12
Editorial: themed issue: understanding the technical and social landscape of gene editing9
Capitalization and the production of value at the nexus of academia and industry: the case of a microbiome startup9
The matrix of stem cell research: an approach to rethinking science in society9
Donors: curious connections in donor conception Donors: curious connections in donor conception , by P. Nordqvist and L. Gilman, Bingley, Emerald Group Publishing, 2022,9
The unexpected and unanticipated announcement of the “world’s first” gene edited babies: breaching, repairing and strengthening community boundaries7
Public concerns about direct-to-consumer DNA test kits: the evidence from survey and social media data6
Consensus too soon: judges’ and lawyers’ views on genetic information use5
Healthcare activism: markets, morals, and the collective good Healthcare activism: markets, morals, and the collective good , edited by Susi Geiger, Oxford, Oxford Unive5
Safe and purposeful genome editing under harmonized regulation for responsible use: views of research experts5
The omics of our lives: practices and policies of direct-to-consumer epigenetic and microbiomic testing companies5
Exploring “quality” in cord blood transfusion: uncertainties, bionetworks, and collaborations4
Laboring bodies and the quantified self4
Freezing fertility: oocyte cryopreservation and the gender politics of aging4
Commoning contingent resources: constructing an Australian stem cell registry3
“It’s personalized, but it’s still bucket based”: the promise of personalized medicine vs. the reality of genomic risk stratification in a breast cancer screening trial3
“We are all cousins.” Belgian ancestry and genomic testing in a close-knit community in Northeastern Wisconsin2
Goffman against DNA: genetic stigma and the use of genetic ancestry tests by white nationalists2
Reinterpreting “genetic identity” in the regulatory and ethical context of heritable genome editing2
Vaccine court – the law and politics of injury2
Toxic disruptions: polycystic ovary syndrome in urban India2
Many thanks for New Genetics and Society reviewers2
Siloed discourses: a year-long study of twitter engagement on the use of CRISPR in food and agriculture2
Building the airplane while flying it: tracking the transformation of novel sequencing practices into clinical services2
0.014400959014893